AllianceBernstein’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.6M | Buy |
|
|||||
|
2025
Q1 | $45.2M | Sell |
|
|||||
|
2024
Q4 | $68.5M | Buy |
|
|||||
|
2024
Q3 | $85.9M | Buy |
|
|||||
|
2024
Q2 | $62.8M | Buy |
|
|||||
|
2024
Q1 | $69.2M | Sell |
|
|||||
|
2023
Q4 | $75.5M | Buy |
|
|||||
|
2023
Q3 | $54.6M | Buy |
|
|||||
|
2023
Q2 | $69.8M | Buy |
|
|||||
|
2023
Q1 | $57.3M | Sell |
|
|||||
|
2022
Q4 | $71.4M | Buy |
|
|||||
|
2022
Q3 | $54.4M | Buy |
|
|||||
|
2022
Q2 | $73.6M | Sell |
|
|||||
|
2022
Q1 | $99.7M | Buy |
|
|||||
|
2021
Q4 | $110M | Buy |
|
|||||
|
2021
Q3 | $104M | Sell |
|
|||||
|
2021
Q2 | $113M | Buy |
|
|||||
|
2021
Q1 | $131M | Sell |
|
|||||
|
2020
Q4 | $164M | Sell |
|
|||||
|
2020
Q3 | $114M | Sell |
|
|||||
|
2020
Q2 | $111M | Buy |
|
|||||
|
2020
Q1 | $62.8M | Sell |
|
|||||
|
2019
Q4 | $66.1M | Buy |
|
|||||
|
2019
Q3 | $57.1M | Buy |
|
|||||
|
2019
Q2 | $74M | Buy |
|
|||||
|
2019
Q1 | $78.4M | Buy |
|
|||||
|
2018
Q4 | $43.8M | Buy |
|
|||||
|
2018
Q3 | $75.8M | Buy |
|
|||||
|
2018
Q2 | $72.4M | Buy |
|
|||||
|
2018
Q1 | $45.8M | Buy |
|
|||||
|
2017
Q4 | $32.5M | Buy |
|
|||||
|
2017
Q3 | $34.3M | Sell |
|
|||||
|
2017
Q2 | $42.8M | Buy |
|
|||||
|
2017
Q1 | $38.9M | Sell |
|
|||||
|
2016
Q4 | $47M | Buy |
|
|||||
|
2016
Q3 | $43.6M | Buy |
|
|||||
|
2016
Q2 | $18.5M | Sell |
|
|||||
|
2016
Q1 | $25.1M | Buy |
|
|||||
|
2015
Q4 | $43.3M | Sell |
|
|||||
|
2015
Q3 | $38.9M | Buy |
|
|||||
|
2015
Q2 | $36.6M | Buy |
|
|||||
|
2015
Q1 | $18.9M | Sell |
|
|||||
|
2014
Q4 | $13.7M | Buy |
|
|||||
|
2014
Q3 | $17.5M | Buy |
|
|||||
|
2014
Q2 | $13.7M | Buy |
|
|||||
|
2014
Q1 | $12.1M | Buy |
|